LeafNLP Demos
Back to explore

Report #2873181

Received Nov 17, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
WI
Recovered
Unknown
Vaccinated
Oct 14, 2024
Onset
Oct 29, 2025
Days to onset
380
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1——
HPV9HPV (GARDASIL 9)MERCK & CO. INC.2——

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

No additional AE/ No PQC reported; received her second dose of the GARDASIL 9 on 10/29/2025 one year and 2 weeks after the first dose; This spontaneous report was received from a consumer referring to a female patient of unknown age (her daughter). The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 14-Oct-2024, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (1 dosage form, strength, route, lot # and expiration date were not reported) for prophylaxis. On 29-Oct-2025 (one year and 2 weeks later), the patient was vaccinated with the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (1 dosage form, strength, route, lot # and expiration date were not reported) for prophylaxis (inappropriate schedule of product administration). It was uncertain if still needed the third dose. No additional adverse event was reported.